This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Boehringer Ingelheim International Gmbh, Ose Immmnotherapeatics Sa. Active years: 2023-2026.
Company Filing History:
2 out of 1,560 
1 out of 1 Years Active: 2023-2026
Title: Eduardo Sergio Trombetta: Innovator in Antibody Therapeutics
Introduction
Eduardo Sergio Trombetta is a notable inventor based in Guilford, CT (US). He has made significant contributions to the field of antibody therapeutics, particularly through his innovative patents. With a total of 2 patents, Trombetta's work focuses on advancing medical treatments and diagnostics.
Latest Patents
One of his latest patents is titled "Anti-SIRP-alpha Antibodies." This invention relates to anti-SIRP-alpha (Signal Regulatory Protein Alpha) antibodies and their antigen-binding fragments. These antibodies are designed for therapeutic and diagnostic methods, showcasing Trombetta's commitment to improving healthcare solutions.
Career Highlights
Throughout his career, Eduardo has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Boehringer Ingelheim International GmbH and Ose Immunotherapeutics SA. His experience in these organizations has allowed him to develop and refine his innovative ideas in antibody research.
Collaborations
Trombetta has collaborated with several professionals in his field, including Pankaj Gupta and Priyanka Gupta. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Eduardo Sergio Trombetta is a distinguished inventor whose work in antibody therapeutics has the potential to impact medical science significantly. His innovative patents and collaborations reflect his dedication to advancing healthcare solutions.